Cargando…

Antibodies to aquaporin-1 are not present in neuromyelitis optica

Detalles Bibliográficos
Autores principales:	Schanda, Kathrin, Waters, Patrick, Holzer, Hannah, Aboulenein-Djamshidian, Fahmy, Leite, M. Isabel, Palace, Jacqueline, Vukusic, Sandra, Marignier, Romain, Berger, Thomas, Reindl, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592537/ https://www.ncbi.nlm.nih.gov/pubmed/26468473 http://dx.doi.org/10.1212/NXI.0000000000000160

Ejemplares similares

Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders
por: Tuller, Friederike, et al.
Publicado: (2016)

Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
por: Mader, Simone, et al.
Publicado: (2010)

Reduction in Serum Aquaporin-4 Antibody Titers During Development of a Tumor-Like Brain Lesion in a Patient With Neuromyelitis Optica: A Serum Antibody–Consuming Effect?
por: Aboulenein-Djamshidian, Fahmy, et al.
Publicado: (2015)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
por: Waters, Patrick, et al.
Publicado: (2016)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
por: Wilson, Robert, et al.
Publicado: (2018)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
por: Jarius, S., et al.
Publicado: (2008)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007)

Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review
por: Papp, Viktoria, et al.
Publicado: (2021)

Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?
por: Reindl, Markus
Publicado: (2020)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

Disease exacerbation after rituximab induction in neuromyelitis optica
por: Perumal, Jai S., et al.
Publicado: (2015)

Mortality in neuromyelitis optica is strongly associated with African ancestry
por: Mealy, Maureen A., et al.
Publicado: (2018)

Longitudinally extensive myelitis in MS mimicking neuromyelitis optica
por: Whittam, Daniel, et al.
Publicado: (2017)

Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders
por: Damato, Valentina, et al.
Publicado: (2022)

Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
por: Hor, Jyh Yung, et al.
Publicado: (2020)

Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder
por: Camera, Valentina, et al.
Publicado: (2021)

Rituximab during pregnancy in neuromyelitis optica: A case report
por: Miranda-Acuña, Jahir, et al.
Publicado: (2019)

The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab
por: Nicolas, Philippe, et al.
Publicado: (2019)

Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease
por: Kaku, Michelle, et al.
Publicado: (2016)

Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy
por: Feyissa, Anteneh M., et al.
Publicado: (2015)

Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
por: Hodecker, Sibylle C., et al.
Publicado: (2017)

Double-negative neuromyelitis optica spectrum disorder
por: Wu, Yan, et al.
Publicado: (2023)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
por: Mader, Simone, et al.
Publicado: (2011)

NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases
por: Ramberger, Melanie, et al.
Publicado: (2015)

Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2020)

Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
por: Camera, Valentina, et al.
Publicado: (2023)

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders
por: Oertel, Frederike Cosima, et al.
Publicado: (2023)

Differential diagnosis of neuromyelitis optica spectrum disorders
por: Kim, Sung-Min, et al.
Publicado: (2017)

Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica
por: Baert, Laurie, et al.
Publicado: (2021)

Demographic and clinical features of neuromyelitis optica: A review
por: Pandit, L, et al.
Publicado: (2015)

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord
por: Oji, Satoru, et al.
Publicado: (2016)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis
por: Matthews, Lucy, et al.
Publicado: (2015)

Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis
por: Juryńczyk, Maciej, et al.
Publicado: (2021)

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid
por: Marignier, R., et al.
Publicado: (2016)

Ependyma: a new target for autoantibodies in neuromyelitis optica?
por: Bigotte, Maxime, et al.
Publicado: (2022)

Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study
por: Demuth, Stanislas, et al.
Publicado: (2022)

Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica
por: Nelson, Patricia A., et al.
Publicado: (2010)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l56nc4avkjtv1oicln8rgcefat